Atlas Trials

San Rocco Therapeutics

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch San Rocco Therapeutics

RecordFirmDate
ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene (NCT01639690)San Rocco Therapeutics2012-07-01

Track San Rocco Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.